Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Besifovir - LG Chem/IlDong Pharmaceuticals

Drug Profile

Besifovir - LG Chem/IlDong Pharmaceuticals

Alternative Names: ANA-380; Besifovir dipivoxil; LB-80380

Latest Information Update: 17 Aug 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator LG Life Sciences
  • Developer Ildong Pharmaceutical; LG Life Sciences
  • Class Antivirals; Hypoxanthines; Phosphonic acids; Purine nucleotides; Small molecules
  • Mechanism of Action DNA-directed DNA polymerase inhibitors; Hepatitis B virus replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Hepatitis B

Most Recent Events

  • 20 Aug 2015 No recent reports on development identified - Phase-II for Hepatitis B (Treatment-naive) in Hong Kong (PO)
  • 20 Aug 2015 No recent reports on development identified - Phase-II for Hepatitis B (Treatment-naive) in South Korea (PO)
  • 10 Nov 2014 Ildong Pharmaceuticals plans a phase I bioequivalence trial in Healthy volunteers in South Korea (NCT02300688)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top